Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a pneumococcal conjugate vaccine tested in adults aged 50 to 84; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease
• Pneumococcal Infection

Drugs mentioned

• Pneumococcal conjugate vaccine (Sanofi)

Snippet

Sponsor: Sanofi | Conditions: Pneumococcal Immunization | Phase 2 | Status: COMPLETED | Results posted: 2024-08-27